Myomo (NYSE:MYO) shares ticked up after hours today on third-quarter results that topped the consensus forecast. MYO shares were up 15.9% at $5.60 per share after hours. The Cambridge, Mass.-based company posted losses of -$2.8 million, or -70¢ per share, on sales of $1.9 million for the three months ended Sept. 30, 2020, for a slight […]
Prosthetics
Myomo names chief medical officer
Myomo (NYSE:MYO) today said it appointed Dr. Harry Kovelman as chief medical officer, effective immediately. Kovelman will be responsible for overseeing the company’s patient advocacy organization. He will work with commercial and government payer organizations to increase patient access to the MyoPro product line. “I’m pleased to welcome Dr. Kovelman to Myomo as we continue to […]
Myomo lands Medicare coverage
Myomo (NYSE:MYO) announced that it received authorization to be a Medicare provider through the Centers for Medicare & Medicaid Services. CMS, under the U.S. Dept. of Health and Human Services, now includes Cambridge, Mass.-based Myomo in its Medicare Supplier Directory at Medicare.gov, which enables Myomo to bill Medicare directly when it delivers its MyoPro orthosis in […]
B-Temia wins FDA clearance for mobility exoskeleton
B-Temia announced today that it received FDA 510(k) clearance for its Keeogo Dermoskeleton human mobility system. Short for “keep on going,” Keeogo is a lower-limb-powered human mobility device with Dermoskeleton lightweight exoskeleton technology that provides what the Quebec City-based company describes in a news release as a “true human-machine interface.” The Keeogo Dermoskeleton is designed […]
Myomo launches MyoCare
Myomo (NYSE:MYO) announced today that it launched its MyoCare program for providing support to first-year users of its MyoPro powered brace. MyoCare offers expanded support to current and future clients who receive their MyoPro directly from the Cambridge, Mass.-based company, at no additional cost. Anyone who obtained the MyoPro from an authorized orthotics & prosthetics clinic […]
Steeper Group acquires College Park Industries’ Espire Elbow
Steeper Group announced today that it completed the acquisition of College Park Industries’ Espire Elbow prostheses range. Leeds, England-based Steeper Group completed the transaction after a COVID-19-forced delay. After the FTC approved Össur’s acquisition of College Park Industries, the three parties agreed to the delay, but are now able to complete the transaction. Espire Elbow […]
Myomo drops on Q4 losses
Myomo (NYSE:MYO) shares took a hit today on fourth-quarter results that missed the consensus forecast for earnings but topped the revenue projections. The Cambridge, Mass.-based commercial-stage medical robotics company yesterday evening posted losses of $2.8 million, or -$4.81 per share, on sales of $1.5 million for the three months ended Dec. 31, 2019, for a 2.6% […]
Myomo shares down on news of $15m public offering
Shares of Myomo (NYSE:MYO) took a dive in price today after the commercial-stage medical robotics company announced it would raise $15 million from a public offering. MYO shares were down nearly 45% to $6.46 apiece by the afternoon. The company — maker of the MyoPro upper limb orthosis — is selling more than 2.1 million shares […]
Myomo stock sees week of volatility
Investors have traded millions of shares in commercial-stage medical robotics company Myomo (NYSE:MYO) this week, with the company saying it is unaware of what is causing the trading volatility. The Cambridge, Mass.–based company on Jan. 30 enacted a 1-for-30 reverse stock split, with stocks slumping for a few days before doubling in value on Tuesday and then […]
Animal OrthoCare gives dog a leg up on life
A Minnesota company is on a mission to develop prosthetics, braces and pain-relief medical devices for animals that are just as good as those made for humans. You may have seen the handiwork of veterinary medical device firm Animal Ortho Care. The company enabled a mini dwarf pony named Pumpkin that was born with four […]
Second Sight beat The Street in Q2 despite $8.44m loss
Second Sight Medical (NSDQ:EYES) posted second-quarter results yesterday that beat both the sales and earnings forecasts on Wall Street as it accelerated its pivot toward manufacturing a new cortical implant. Citing the costs of reorganization, the Sylmar, Calif.-based company reported a loss of $8.44 million, or -0.07¢ per share, on sales of $1.28 million for […]
